1571. In Vitro Activity of Ceftazidime-Avibactam and Comparator Agents Against MDR Enterobacterales and Pseudomonas aeruginosa Collected in Latin America During the ATLAS Global Surveillance Program 2017-2018

BACKGROUND: Ceftazidime-avibactam (CAZ-AVI) is a β-lactam/non-β-lactam β-lactamase inhibitor combination that can inhibit class A, C and some class D β-lactamases. Resistance caused by these β-lactamases often results in multidrug-resistance (MDR). This study evaluated the in vitro activity of CAZ-A...

Descripción completa

Detalles Bibliográficos
Autores principales: Kazmierczak, Krystyna, Lob, Sibylle, Stone, Greg, Sahm, Daniel F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778193/
http://dx.doi.org/10.1093/ofid/ofaa439.1751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778193/
http://dx.doi.org/10.1093/ofid/ofaa439.1751

Ejemplares similares